C. Felley

发表

Impairment of glucose disposal by infusion of triglycerides in humans: role of glycemia.

E. Jéquier, J. Felber, P. Frascarolo, 1989, The American journal of physiology.

Inflammatory Gene Profiles in Gastric Mucosa during Helicobacter pylori Infection in Humans1

Mark Reimers, Sicheng Wen, Q. Pan-Hammarström, 2004, The Journal of Immunology.

Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT II.

V. Pittet, F. Froehlich, J. Gonvers, 2009, Journal of Crohn's & colitis.

CT enteroclysis: technique and clinical applications

P. Schnyder, J. Meuwly, S. Schmidt, 2006, European Radiology.

Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).

B. Burnand, V. Pittet, J. Vader, 2009, International journal of epidemiology.

The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case–control study

A. Telenti, M. Battegay, H. Furrer, 2004, AIDS.

Regulation of glucose storage in obesity and diabetes: metabolic aspects.

E. Jéquier, A. Golay, J. Felber, 1988, Diabetes/metabolism reviews.

Interaction of lipid and carbohydrate metabolism after infusions of lipids or of lipid lowering agents: lack of a direct relationship between free fatty acid concentrations and glucose disposal.

E. Jéquier, A. Golay, J. Felber, 1992, Diabete & metabolisme.

Resistance to insulin mediated glucose disposal in obese subjects: respective effect of lipid metabolism and glycemia.

E. Jéquier, J. Felber, P. Frascarolo, 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett's esophagus after oral administration of aminolevulinic acid.

T. Gabrecht, P. Grosjean, G. Wagnières, 2003, Endoscopy.

Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.

C. Sokollik, J. Borovička, T. Hinterleitner, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Safety of Infliximab in Patients Suffering from Inflammatory Bowel Disease

C. Felley, P. Michetti, 2004, Digestion.

Appropriateness of therapy for fistulizing Crohn’s disease: findings from a national inflammatory bowel disease cohort

G. Rogler, B. Burnand, C. Beglinger, 2010, Alimentary pharmacology & therapeutics.

Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness

G. Rogler, B. Burnand, F. Seibold, 2010, European journal of gastroenterology & hepatology.

Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT II.

C. O'Morain, V. Pittet, F. Froehlich, 2009, Journal of Crohn's & colitis.

S1028 Appropriate Maintenance Treatment for Crohn's Disease: Results of a Multidisciplinary International Expert Panel - EPACT II

W. Bemelman, V. Pittet, F. Froehlich, 2009 .

Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II.

F. Seibold, V. Pittet, F. Froehlich, 2009, Journal of Crohn's & colitis.

Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT II.

W. Bemelman, V. Pittet, F. Froehlich, 2009, Journal of Crohn's & colitis.

Evaluating Appropriateness of Treatment for Crohn’s Disease: Feasibility of an Explicit Approach

B. Burnand, I. Guessous, V. Pittet, 2007, Digestion.

Appropriate Treatment for Crohn’s Disease: Methodology and Summary Results of a Multidisciplinary International Expert Panel Approach – EPACT

B. Burnand, V. Pittet, F. Froehlich, 2006, Digestion.

Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice

Simon F Brunner, C. Sokollik, J. Borovička, 2020, Communications Biology.

Effect of Whey-Based Culture Supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori Infection in Humans

A. Blum, D. Brassart, G. Dorta, 1999, Digestion.

Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26‐week data of the FACTS II survey

G. Rogler, A. Schoepfer, A. Straumann, 2011, Inflammatory bowel diseases.

Oxidative Stress in Gastric Mucosa of Asymptomatic Humans Infected with Helicobacter pylori: Effect of Bacterial Eradication

M. Stolte, C. Felley, G. V. van Melle, 2002, Helicobacter.

EPACT II: Project and Methods

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Prevalence of lnflammatory Bowel Disease in the Canton of Vaud ( Switzerland ) : A population-based cohort study *

J. Bulliard, I. Guessous, V. Pittet, 2014 .

Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study.

J. Bulliard, I. Guessous, V. Pittet, 2008, Journal of Crohn's & colitis.

Disabling pelvic pain following open surgery for rectal prolapse: a case report

N. Demartines, C. Felley, M. Matter, 2009, Journal of Medical Case Reports.

Pregnancy and Breastfeeding in Patients with Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Pregnancy and Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

Drug Safety in Crohn’s Disease Therapy

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Drug Safety in the Treatment of Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man

A. Blum, A. Pfeifer, D. Brassart, 2001, European journal of gastroenterology & hepatology.

The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients

M. Preisig, C. Sokollik, J. Borovička, 2022, Journal of Gastroenterology.

Mild-to-Moderate Active Luminal Crohn’s Disease

C. Felley, P. Michetti, Pascal Juillerat, 2008, Digestion.

Maintenance of Medically Induced Remission of Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Therapy of Mild to Moderate Luminal Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

Maintenance of Remission in Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease

G. Rogler, A. Schoepfer, A. Straumann, 2012, Inflammatory bowel diseases.

The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients

M. Preisig, C. Sokollik, J. Borovička, 2022, Journal of Gastroenterology.

Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort

B. Burnand, V. Pittet, F. Froehlich, 2010, Scandinavian journal of gastroenterology.

Maintenance of Surgically Induced Remission of Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study

C. Sokollik, J. Borovička, T. Hinterleitner, 2018, Journal of Crohn's & colitis.

Severe and Steroid-Resistant Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey†

G. Rogler, A. Schoepfer, A. Straumann, 2010, Inflammatory bowel diseases.

Lower Risk of B1-to-pB3-Stage Migration in Crohn’s Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study

C. Sokollik, J. Borovička, T. Hinterleitner, 2019, Digestive Diseases and Sciences.

Comment on “Resistin-Like Molecule β (RELMβ/FIZZ2) Is Highly Expressed in the Ileum of SAMP1/YitFc Mice and Is Associated with Initiation of Ileitis”

Q. Pan-Hammarström, C. Felley, P. Michetti, 2008, The Journal of Immunology.

MALT Lymphoma in Sjögren's Syndrome'' Neogenesis in Autoimmune Sialoadenitis and Supports Functionality of Ectopic Lymphoid Networks and Interfollicular Large B Cells Expression in Follicular Dendritic Cell ''Activation-Induced Cytidine Deaminase Response to Comment on

Q. Pan-Hammarström, C. Felley, P. Michetti, 2008 .

and Is Associated with Initiation of Ileitis''Mice Expressed in the Ileum of SAMP1/YitFc /FIZZ2) Is Highly b (RELM b Molecule Response to Comment on ''Resistin-Like

Q. Pan-Hammarström, C. Felley, P. Michetti, 2008 .

Comment on “TCR Activation Eliminates Glutamate Receptor GluR3 from the Cell Surface of Normal Human T Cells, via an Autocrine/Paracrine Granzyme B-Mediated Proteolytic Cleavage”

Q. Pan-Hammarström, C. Felley, P. Michetti, 2008 .

Short-term infusions of insulin, triacylglycerol and glucose do not cause acute increases in plasminogen activator inhibitor-1 concentrations in man.

J. Felber, E. Kruithof, C. Felley, 1990, Clinical science.

Extraintestinal Manifestations of Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2005, Digestion.

Engineered lymphocytes to treat dinitrobenzene sulphonic acid colitis in mice

C. Felley, P. Michetti, 2003, European journal of gastroenterology & hepatology.

Extraintestinal Manifestations of Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

Probiotics and Helicobacter pylori.

C. Felley, P. Michetti, 2003, Best practice & research. Clinical gastroenterology.

Microbial network disturbances in relapsing refractory Crohn’s disease

J. Stelling, C. Sokollik, J. Borovička, 2019, Nature Medicine.

Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice

C. Sokollik, J. Borovička, F. Ris, 2020, Communications Biology.

Severe and Steroid-Resistant Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

[De novo inflammatory bowel diseases after liver transplantation: description of four new cases and a review of the literature].

C. Felley, P. Michetti, M. Maillard, 2006, Gastroenterologie clinique et biologique.

Diagnostic performance of MRI for detection of intestinal fistulas in patients with complicated inflammatory bowel conditions

R. Meuli, P. Schnyder, S. Schmidt, 2007, European Radiology.

Brunner gland hamartoma: a challenging diagnosis.

A. Denys, M. Vernez, C. Felley, 2006, Pancreas.

Prospective comparison of MR enteroclysis with multidetector spiral-CT enteroclysis: interobserver agreement and sensitivity by means of "sign-by-sign" correlation

Reto Meuli, Pierre Schnyder, Domenico Lepori, 2003, European Radiology.

Recurrent Acute Pancreatitis and Therapy for Ulcerative Colitis

C. Felley, J. Frossard, P. Michetti, 2010, Case Reports in Gastroenterology.

Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study

C. Sokollik, J. Borovička, F. Ris, 2023, BMC Gastroenterology.

Comparison between esophageal Wallstent and Ultraflex stents in the treatment of malignant stenoses of the esophagus and cardia.

A. Blum, G. Dorta, C. Felley, 1997, Endoscopy.

Upper Gastrointestinal Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Treatment of Gastroduodenal Crohn’s Disease

F. Froehlich, J. Gonvers, C. Felley, 2005, Digestion.

Evaluating the cost-effectiveness of early compared to late or no biologic treatment to manage Crohn's disease using real world data.

C. S. Sutherland, C. Sokollik, J. Borovička, 2019, Journal of Crohn's & colitis.

TNF-alpha blockers in inflammatory bowel diseases: practical consensus recommendations and a user's guide.

G. Rogler, C. Felley, I. Pache, 2009, Swiss medical weekly.

When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel.

B. Burnand, A. Schoepfer, V. Pittet, 2013, Journal of Crohn's & colitis.

Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).

C. Sokollik, J. Borovička, T. Hinterleitner, 2019, International journal of epidemiology.

Treatment of Postoperative Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

Genotype–phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients

C. Sokollik, J. Borovička, F. Ris, 2021, BMC Gastroenterology.

The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO‐EpiCom Study of 209 pregnant women

J. Gisbert, D. Hommes, V. Annese, 2013, Alimentary pharmacology & therapeutics.

in Humans Infection Helicobacter pylori Mucosa during Inflammatory Gene Profiles in Gastric

Q. Pan-Hammarström, C. Felley, H. Bouzourène, 2017 .

Chief cells possess a receptor with high affinity for PACAP and VIP that stimulates pepsinogen release.

R. Jensen, C. Felley, T. Pradhan, 1992, The American journal of physiology.

Calprotectin in Daily Practice: Where Do We Stand in 2017?

C. Felley, J. Frossard, F. D'angelo, 2017, Digestion.

Combined written and oral information prior to gastrointestinal endoscopy compared with oral information alone: a randomized trial

T. Perneger, G. Dorta, C. Felley, 2008, BMC gastroenterology.

Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia.

L. Spahr, G. Dorta, C. Felley, 2012, World journal of gastroenterology.

Comparison of Immunochemical and Guaiac-Based Occult Fecal Tests with Colonoscopy Findings in Symptomatic Patients

L. Spahr, C. Felley, J. Frossard, 2009 .

Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management

C. Sokollik, N. Beerenwinkel, J. Borovička, 2021, BMC Gastroenterology.

Bombesin does not stimulate pepsinogen release in isolated gastric chief cells

R. Jensen, R. Benya, C. Felley, 1995, Peptides.

Chief cells possess somatostatin receptors regulated by secretagogues acting through the calcium or cAMP pathway.

R. Jensen, D. Coy, C. Felley, 1994, The American journal of physiology.

Unusual Masses of the Pancreas to Be Aware of

P. Morel, T. Berney, S. Terraz, 2009, Case Reports in Gastroenterology.

Biliary migration of hepatocellular carcinoma fragment after transcatheter arterial chemoembolization therapy.

P. Majno, L. Spahr, C. Felley, 2000, European journal of gastroenterology & hepatology.

L. acidophilus supernantant as an adjuvant in the therapy of H. pylori in humans

A. Blum, G. Dorta, I. Corthésy-Theulaz, 1995 .

Acute Complications of Crohn’s Disease: Comparison of Multidetector-Row Computed Tomographic Enterography with Magnetic Resonance Enterography

R. Meuli, P. Schnyder, J. Meuwly, 2010, Digestion.

Expression of Helicobacter pylori Virulence Factors and Associated Expression Profiles of Inflammatory Genes in the Human Gastric Mucosa

Likun Du, Q. Pan-Hammarström, C. Felley, 2007, Infection and Immunity.

Obstructive Fibrostenotic Crohn’s Disease

B. Burnand, F. Froehlich, J. Gonvers, 2005, Digestion.

Perceived Behavioral Changes in Early Multiple Sclerosis

J. Annoni, L. Bruggimann, M. Schluep, 2007, Behavioural neurology.

[Ultrasound examination of non-traumatic acute abdomen].

P. Schnyder, C. Felley, J. Meuwly, 2002, Ultraschall in der Medizin.

Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study

J. Bulliard, I. Guessous, V. Pittet, 2008 .

Subject Index Vol. 73, 2006

J. Mate, J. Gisbert, E. Savarino, 2006, Digestion.

Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease

C. Sokollik, N. Beerenwinkel, J. Borovička, 2018, Alimentary pharmacology & therapeutics.

Maintenance of Surgically Induced Remission of Crohn’s Disease

V. Pittet, F. Froehlich, J. Gonvers, 2008, Digestion.

Acute Complications of Crohn’s Disease: Comparison of Multidetector-Row Computed Tomographic Enterography with Magnetic Resonance Enterography

R. Meuli, P. Schnyder, J. Meuwly, 2010, Digestion.

Genotype–phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients

C. Sokollik, T. Hinterleitner, G. Rogler, 2021, BMC Gastroenterology.